{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:42:45Z","timestamp":1785422565261,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"SAMRC","doi-asserted-by":"publisher","award":["RFA-EMU-02\\u20132017"],"award-info":[{"award-number":["RFA-EMU-02\\u20132017"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"EDCTP","doi-asserted-by":"publisher","award":["TMA2019CDF-2780"],"award-info":[{"award-number":["TMA2019CDF-2780"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpba.2025.117093","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:54:40Z","timestamp":1754520880000},"page":"117093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Validation and clinical application of an LC-MS\/MS method designed to simultaneously measure seven second-line TB drugs and two metabolites in human lung tissue"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-4106","authenticated-orcid":false,"given":"Katie Kriegler","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-5804","authenticated-orcid":false,"given":"Anil","family":"Pooran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthinus","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-9883","authenticated-orcid":false,"given":"Sandra","family":"Castel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Zangenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9070-8699","authenticated-orcid":false,"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117093_bib1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline resistance: its emergence, mechanism, and prevention","volume":"66","author":"Nguyen","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2025.117093_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac029","article-title":"Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review","volume":"4","author":"Mallick","year":"2022","journal-title":"JAC Antimicrob. Resist"},{"key":"10.1016\/j.jpba.2025.117093_bib3","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1038\/s41467-024-48515-7","article-title":"Heterogeneity in lung macrophage control of mycobacterium tuberculosis is modulated by t cells","volume":"15","author":"Lai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2025.117093_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S2213-2600(14)70031-1","article-title":"Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis","volume":"2","author":"Dheda","year":"2014","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.jpba.2025.117093_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-015-0531-3","article-title":"Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis","volume":"38","author":"Dorhoi","year":"2016","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.jpba.2025.117093_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024770","article-title":"Clonal population of mycobacterium tuberculosis strains reside within multiple lung cavities","volume":"6","author":"Vadwai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.117093_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157488410791110797","article-title":"Clinical pharmacology and lesion penetrating properties of Second- and Third-Line antituberculous agents used in the management of Multidrug-Resistant (MDR) and Extensively-Drug resistant (XDR) tuberculosis","volume":"5","author":"Dartois","year":"2010","journal-title":"Curr. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117093_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002773","article-title":"Tuberculosis drugs\u2019 distribution and emergence of resistance in patient\u2019s lung lesions: a mechanistic model and tool for regimen and dose optimization","volume":"16","author":"Strydom","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jpba.2025.117093_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/jac\/dkae109","article-title":"Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling","volume":"79","author":"Karakitsios","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2025.117093_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40262-023-01217-7","article-title":"Predictions of bedaquiline and pretomanid target attainment in lung lesions of tuberculosis patients using translational minimal physiologically based pharmacokinetic modeling","volume":"62","author":"Mehta","year":"2023","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117093_bib11","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4155\/bio.12.252","article-title":"Bioanalysis of drug in tissue: current status and challenges","volume":"4","author":"Xue","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib12","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/bio.14.34","article-title":"Recommendations from the european bioanalysis forum on method establishment for tissue homogenates","volume":"6","author":"Timmerman","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib13","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4155\/bio.12.237","article-title":"Evaluation of surrogate matrices for standard curve preparation in tissue bioanalysis","volume":"4","author":"Chen","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib14","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.4155\/bio.12.230","article-title":"A primer for best practices in tissue preparation for bioanalysis","volume":"4","author":"Kemper","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib15","series-title":"Food and drug administration, guidance for industry: bioanalytical method validation","author":"U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.jpba.2025.117093_bib16","unstructured":"European Medicines Agency, Guidelines for bioanalytical method validation, London, 2012."},{"key":"10.1016\/j.jpba.2025.117093_bib17","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3390\/pharmaceutics15112543","article-title":"A Single-Run HPLC\u2013MS multiplex assay for therapeutic drug monitoring of relevant First- and Second-Line antibiotics in the treatment of Drug-Resistant tuberculosis","volume":"15","author":"K\u00f6hler","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2025.117093_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124470","article-title":"Development and validation of an LC-MS\/MS multiplex assay for the quantification of bedaquiline, n-desmethyl bedaquiline, linezolid, levofloxacin, and clofazimine in dried blood spots","volume":"1252","author":"Kenfack Teponnou","year":"2025","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.117093_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1164\/rccm.201711-2333OC","article-title":"Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis","volume":"198","author":"Dheda","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.jpba.2025.117093_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4236\/ajac.2015.62009","article-title":"Liquid chromatography-tandem mass spectrometry methods for determination of delamanid in mouse plasma and lung","volume":"06","author":"Hirao","year":"2015","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117093_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4155\/bio.12.19","article-title":"Tissue sample preparation in bioanalytical assays","volume":"4","author":"Smith","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib22","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117093_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC\u2013MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.117093_bib24","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/jac\/dkac067","article-title":"Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)","volume":"77","author":"Upton","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2025.117093_bib25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.4155\/bio.15.161","article-title":"Surrogate matrix: opportunities and challenges for tissue sample analysis","volume":"7","author":"Ho","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117093_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02571-20","article-title":"Prediction of human pharmacokinetic profiles of the antituberculosis drug delamanid from nonclinical data: potential therapeutic value against extrapulmonary tuberculosis","volume":"65","author":"Shibata","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117093_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in mycobacterium tuberculosis infected C3HeB\/FeJ mice","volume":"2","author":"Irwin","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jpba.2025.117093_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02399-20","article-title":"Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with Rifampin-Resistant tuberculosis","volume":"65","author":"Ngwalero","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2025.117093_bib29","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1183\/09031936.00047413","article-title":"Drug concentration in lung tissue in multidrug-resistant tuberculosis","volume":"42","author":"Akkerman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jpba.2025.117093_bib30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat. Med"},{"key":"10.1016\/j.jpba.2025.117093_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/etm.2020.8715","article-title":"Pharmacokinetics and pharmacodynamics of levofloxacin in bronchial mucosa and lung tissue of patients undergoing pulmonary operation","volume":"20","author":"Cao","year":"2020","journal-title":"Exp. Ther. Med"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525004340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525004340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:29:34Z","timestamp":1772796574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525004340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0731708525004340"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117093","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and clinical application of an LC-MS\/MS method designed to simultaneously measure seven second-line TB drugs and two metabolites in human lung tissue","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117093"}}